Robert E. Pelzer
Direktor/Vorstandsmitglied bei Qu Biologics, Inc.
Aktive Positionen von Robert E. Pelzer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Robert E. Pelzer
Ehemalige bekannte Positionen von Robert E. Pelzer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SIERRA ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 01.05.2015 | 22.11.2019 |
Vorsitzender | 22.11.2019 | 01.07.2022 | |
Independent Dir/Board Member | 01.05.2015 | 01.07.2022 | |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 01.06.2013 | 09.08.2019 |
Independent Dir/Board Member | 01.06.2013 | 09.08.2019 | |
IDENIX PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 01.05.2003 | 31.12.2012 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | General Counsel | 01.03.2002 | 01.08.2008 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Vorstandsvorsitzender | - | - |
General Counsel | - | 01.01.2008 | |
Präsident | - | 01.01.2008 | |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | General Counsel | 01.01.1998 | 01.01.2001 |
ContextMedia Health LLC
ContextMedia Health LLC Medical/Nursing ServicesHealth Services Contextmedia Health LLC owns and operates a digital healthcare networks. It provides condition-specific programming and ad-supported content at point-of-care facilities. The firm also empowers healthcare professionals to engage patients while curating content personalized for each member office. The company was founded by Shradha Agarwal and Rishi U. Shah in 2006 and is headquartered in Chicago, IL. | Direktor/Vorstandsmitglied | 31.05.2018 | - |
MacKimmie Matthews | Corporate Officer/Principal | - | - |
░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░ ░░░░░░░ | - | - |
Ausbildung von Robert E. Pelzer
University of Alberta | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Kanada | 6 |
Schweiz | 2 |
Operativ
Director/Board Member | 5 |
General Counsel | 5 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 2 |
Energy Minerals | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 11 |
---|---|
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Conoco Canada Ltd.
Conoco Canada Ltd. Oil & Gas ProductionEnergy Minerals Part of ConocoPhillips, Conoco Canada Ltd. is the Canadian division of ConocoPhillips, the world's largest independent exploration and production company based on production and proved reserves. ConocoPhillips explores for, develops, and produces crude oil and natural gas in Canada. | Energy Minerals |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
MacKimmie Matthews | |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
ContextMedia Health LLC
ContextMedia Health LLC Medical/Nursing ServicesHealth Services Contextmedia Health LLC owns and operates a digital healthcare networks. It provides condition-specific programming and ad-supported content at point-of-care facilities. The firm also empowers healthcare professionals to engage patients while curating content personalized for each member office. The company was founded by Shradha Agarwal and Rishi U. Shah in 2006 and is headquartered in Chicago, IL. | Health Services |
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
- Börse
- Insiders
- Robert E. Pelzer
- Erfahrung